{"status": "ok", "totalResults": 3, "articles": [{"source": {"id": null, "name": "Business Insider India"}, "author": "Business Insider India", "title": "Pfizer vaccine less effective against COVID-19 in kids aged 5-11: Study - Business Insider India", "description": "<ol><li>Pfizer vaccine less effective against COVID-19 in kids aged 5-11: Study\u00a0\u00a0Business Insider India\r\n</li><li>Coronavirus vaccine: Pfizer vaccine less effective in 5-11 year olds, finds study\u00a0\u00a0Times of India\r\n</li><li>Pfizer Covid vaccine was just 12% eff\u2026", "url": "https://www.businessinsider.in/international/news/pfizer-vaccine-less-effective-against-covid-19-in-kids-aged-5-11-study/articleshow/89924958.cms", "urlToImage": "https://www.businessinsider.in/photo/72107402/businessinsider-default.jpg", "publishedAt": "2022-03-01T11:51:00Z", "content": "Washington, Mar 1 (PTI) The effectiveness of the Pfizer COVID-19 vaccine for children waned quickly during the Omicron surge in the US, especially among those aged 5 to 11 years, but the preventive w\u2026 [+1891 chars]"}, {"source": {"id": null, "name": "Business Insider India"}, "author": "Business Insider India", "title": "Singapore-based Volopay has raised $29 million to expand to India - Business Insider India", "description": "Singapore-based fintech platform Volopay on Tuesday said it has raised $29 million from Winklevoss twins -- Cameron and Tyler -- along with a global decacorn and others to enter the Indian market.", "url": "https://www.businessinsider.in/business/startups/news/singapore-based-volopay-has-raised-29-million-to-expand-to-india/articleshow/89919096.cms", "urlToImage": "https://www.businessinsider.in/photo/89919096/singapore-based-volopay-has-raised-29-million-to-expand-to-india.jpg", "publishedAt": "2022-03-01T07:59:00Z", "content": "Singapore-based fintech platform Volopay\r\n on Tuesday said it has raised $29 million from Winklevoss twins -- Cameron and Tyler -- along with a global decacorn and others to enter the Indian market.\r\u2026 [+1385 chars]"}, {"source": {"id": null, "name": "Business Insider India"}, "author": "Lauren Frias", "title": "Pfizer COVID-19 vaccine may be less effective in young children ages 5-11, new data shows - Business Insider India", "description": "<ol><li>Pfizer COVID-19 vaccine may be less effective in young children ages 5-11, new data shows\u00a0\u00a0Business Insider India\r\n</li><li>Coronavirus vaccine: Pfizer vaccine less effective in 5-11 year olds, finds study\u00a0\u00a0Times of India\r\n</li><li>Pfizer Covid vaccin\u2026", "url": "https://www.businessinsider.in/science/news/pfizer-covid-19-vaccine-may-be-less-effective-in-young-children-ages-5-11-new-data-shows/articleshow/89911511.cms", "urlToImage": "https://www.businessinsider.in/photo/89911511/pfizer-covid-19-vaccine-may-be-less-effective-in-young-children-ages-5-11-new-data-shows.jpg?imgsize=1457758", "publishedAt": "2022-03-01T00:54:00Z", "content": "The Pfizer COVID-19 vaccine\r\n may be far less effective in young children ages 5-11 compared to older children and adults, new data found.\r\nData collected by health officials in New York State looked\u2026 [+1813 chars]"}]}